Mineharu, Y., Oichi, Y., Kamata, T., Matsui, Y., Morimoto, T., Tanji, M., . . . Miyamoto, S. (2020). MBRS-22. SIGNIFICANCE OF RNF213 IN TUMORGENICITY OF MEDULLOBLASTOMA. Neuro Oncol.
Chicago Style CitationMineharu, Yohei, et al. "MBRS-22. SIGNIFICANCE OF RNF213 IN TUMORGENICITY OF MEDULLOBLASTOMA." Neuro Oncol 2020.
Cita MLAMineharu, Yohei, et al. "MBRS-22. SIGNIFICANCE OF RNF213 IN TUMORGENICITY OF MEDULLOBLASTOMA." Neuro Oncol 2020.
Atenció: Aquestes cites poden no estar 100% correctes.